Advocates say closing violence against women must be top priority for U.

This article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health Information, an editorially independent news service, is a scheduled plan of the Kaiser Family members Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.. Advocates say closing violence against women must be top priority for U.N. Women Nearly three quarters of women’s rights advocates say ending violence against women must be a high priority for U.N. Ladies, according to a written report released Wednesday at the Commission on the Status of Women in New York, Inter Press Service reports. Released a day prior to the official launch of the new agency, the ‘Blueprint for U.N.The money was world-wide raised by AkzoNobel workers, of September who took part in various sporting activities during the month.

ACT Biotech reports positive interim data from Telatinib Phase 2 trial for advanced gastric cancer ACT Biotech Inc. This proof-of-concept, multi-center, open up label trial was made to test the basic safety and efficacy of full-dose Telatinib, administered continuously, as a first-line treatment in combination with a standard regimen of capecitabine and cisplatin in US and European patients.